Dasatinib, 5 g

Dasatinib is supplied to meet the demands of controlled research workflows, presented as a 5 g package of crystalline solid. This compound, belonging to the class of tyrosine kinase inhibitors, features a molecular formula of C27H31N7O3S and a molecular weight of 531.62 g/mol. Dasatinib is structurally related to imatinib, sharing a common scaffold, but with an additional methyl group at the 3-position of the pyridine ring. It is primarily used in the treatment of chronic myeloid leukemia and acute lymphoblastic leukemia, demonstrating potent activity against BCR-ABL1, SRC family kinases, and platelet-derived growth factor receptors. Additionally, it has been shown to exhibit antiproliferative effects against various cancer cell lines.

• CAS Number: 302962-49-8